Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-05

Clinical Trial Update: Open-label MNS for Tourette Syndrome [NA]

View source ↗

Summary

Open-label trial update for MNS therapy in Tourette Syndrome shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MNS

Snippet

Sponsor: Washington University School of Medicine | Conditions: Tourette Syndrome, Tic Disorder, Chronic Motor or Vocal | NA | Status: COMPLETED | Results posted: 2023-10-05